En un ensayo clnico de fase 2, la semaglutida a dosis de 0,4mg diarios mostr una resolucin de NASH (sin empeoramiento de fibrosis) en un 59% de los pacientes, comparado con un 14% en el grupo placebo, en 320 pacientes con obesidad, NASH y fibrosis F2-F3 tras 72 semanas de tratamiento
Glutathione exists in two forms: reduced glutathione (GSH), the active antioxidant form, and oxidised glutathione (GSSG), which is recycled back to GSH by glutathione reductase using NADPH as a cofactor
Activation of NRF2-mediated antioxidant enzymes has been shown to enhance the biogenesis of mitochondria in mice and humans (Piantadosi et al., 2008
R., Fietze, I., Weaver, T
In the 68-week Phase 3 STEP TEENS trial, weekly semaglutide (2.4 mg) plus lifestyle produced a mean 16.1% change in BMI from baseline vs
It built on an analysis of social media posts on the community network Reddit, in which users reported reduced cravings for alcohol when taking drugs intended to treat Type 2 diabetes and obesity